News

Gladstone in the News November 8, 2024

Unraveling COVID’s Pernicious Role in Brain Fog and Clotting

Bloomberg—Katerina Akassoglou, a neurovascular brain immunologist at Gladstone, and her team discovered that beyond serving as the virus’s “key” to enter cells, spike binds with a blood clotting factor called fibrinogen, causing a cascade of events that contribute to the neurological symptoms of long COVID.

COVID-19 Akassoglou Lab

Article October 17, 2024

A New Era of Treating Neurological Diseases at the Blood-Brain-Immune Interface

Gladstone scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.

News Release Research (Publication) Alzheimer’s Disease Dementia Multiple Sclerosis Parkinson’s Disease Neurological Disease Akassoglou Lab

Gladstone in the News September 26, 2024

New Study from SF Gladstone Institutes Sheds Light on Cause of Brain Fog Due to COVID-19

ABC7 News—The most commonly reported symptom of long COVID is brain fog, which interferes with your ability to think clearly, remember things, and focus on a task. Senior Investigator Katerina Akassoglou explains the findings from her study that shed new light on what causes brain fog and the many other brain-related symptoms of long COVID and COVID-19.

Gladstone Experts COVID-19 Akassoglou Lab

Gladstone in the News August 29, 2024

Blood Clotting Protein Discovery Upends Conventional COVID-19 Thinking, IDs Potential Therapy

Inside Precision Medicine—A new study by Gladstone Senior Investigators Katerina Akassoglou and Warner Greene shows that fibrin, a blood coagulation protein, drives the cascade of symptoms that are the hallmarks of infection by the SARS-CoV-2 virus.

Gladstone Experts COVID-19 Akassoglou Lab

Article August 28, 2024

Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy

A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.

News Release Research (Publication) COVID-19 Neurological Disease Virology Akassoglou Lab

Article July 23, 2024

Preventing Brain Damage in Preterm Babies

Researchers identify a root cause of developmental delays that result from brain bleeds in premature infants, opening a path for new therapeutic strategies to counter long-term health risks

News Release Research (Publication) Neurological Disease Center for Neurovascular Brain Immunology Akassoglou Lab

Article April 19, 2024

A New Therapeutic Target for Traumatic Brain Injury

Research from Gladstone Institutes reveals that a blood coagulation protein is responsible for initiating toxic inflammation and neuron loss after a major head injury. The findings can inform new treatment strategies for a condition that often presents long-term health challenges.

News Release Dementia Traumatic Brain Injury Neurological Disease Akassoglou Lab

Article June 8, 2023

Revealing How Blood Triggers Brain Disease

New research into how blood makes the brain’s immune cells toxic points to new treatments for Alzheimer’s disease and multiple sclerosis

News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab Krogan Lab Pico

Article March 20, 2023

Solving the Aftermath of Brain and Spinal Cord Injuries

Gladstone scientists make headway toward new treatments for people with chronic long-term effects

Gladstone Experts Traumatic Brain Injury Neurological Disease Akassoglou Lab Paz Lab Srivastava Lab Deep Dive

Gladstone in the News March 9, 2022

COVID-19 Linked to Neurological Symptoms, Studies Show

abc7 news—Senior Investigator Katerina Akassoglou, PhD, commenting on two recent studies that show long-term neurological symptoms in some COVID-19 patients, suggests that these symptoms could result from blood leaks into the brain, which can happen even during a minor infection.

Gladstone Experts COVID-19 Neurological Disease Akassoglou Lab

Article January 26, 2022

Katerina Akassoglou Elected Lifetime AAAS Fellow

Gladstone investigator receives distinct honor within the scientific community

Awards News Release Neurological Disease Akassoglou Lab

Article December 7, 2021

Katerina Akassoglou Elected to National Academy of Inventors

Gladstone scientist receives highest distinction for academic inventors

Awards News Release Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Akassoglou Lab

Gladstone in the News October 7, 2021

Meet the Most Influential Women in Bay Area Business, Class of 2021

San Francisco Business Times—Senior Investigator Katerina Akassoglou, PhD, was picked by the San Francisco Business Times as one of the most influential women in business in the Bay Area this year.

Gladstone Experts Center for Neurovascular Brain Immunology Akassoglou Lab Diversity

Article August 24, 2021

Overcoming Obstacles to Promote Repair in Multiple Sclerosis

Study points to a new promising therapy against toxic blood leaks in the brain

News Release Research (Publication) Alzheimer’s Disease Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab

Article March 26, 2021

Leading the Way to Better Treatments for People with Epilepsy

Gladstone researchers harness unique tools and perspectives to study life-threatening seizures that lack a cure

Gladstone Experts Epilepsy Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab Mucke Lab Palop Lab Paz Lab Deep Dive